| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $70.8M | — | -10.9% |
| R&D Expense | $9.8M | — | -35.6% |
| SG&A Expense | $14.0M | — | -1.4% |
| Operating Income | -$106.5M | — | -427.9% |
| Income Tax | $414K | — | +92.6% |
| Net Income | -$111.0M | — | -367.6% |
| EPS (Basic) | -$1.53 | — | -337.1% |
| EPS (Diluted) | -$1.53 | — | -337.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $59.9M | +17.8% | -82.5% |
| Short-term Investments | $49.0M | +9.0% | — |
| Accounts Receivable | $59.1M | +0.0% | -7.7% |
| Current Assets | $182.3M | +7.7% | -56.9% |
| Total Assets | $412.2M | -18.0% | -53.8% |
| Current Liabilities | $107.6M | +20.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $18.5M | — | +6511.1% |
| Capital Expenditures | $338K | — | -49.6% |
| Investing Cash Flow | -$9.4M | — | -109.7% |
| Financing Cash Flow | -$4K | — | +99.9% |
| Free Cash Flow | $18.2M | — | +4759.7% |
| -68.3% |
| Long-term Debt | $153.4M | +0.1% | -59.9% |
| Total Liabilities | $274.1M | +6.7% | -46.8% |
| Stockholders' Equity | $138.1M | -43.8% | -63.3% |